Pyroptosis: mechanisms and diseases
P Yu, X Zhang, N Liu, L Tang, C Peng… - Signal transduction and …, 2021 - nature.com
Currently, pyroptosis has received more and more attention because of its association with
innate immunity and disease. The research scope of pyroptosis has expanded with the …
innate immunity and disease. The research scope of pyroptosis has expanded with the …
The potential role of RNA N6-methyladenosine in Cancer progression
T Wang, S Kong, M Tao, S Ju - Molecular cancer, 2020 - Springer
Abstract N6-methyladenosine (m6A) is considered the most common, abundant, and
conserved internal transcript modification, especially in eukaryotic messenger RNA (mRNA) …
conserved internal transcript modification, especially in eukaryotic messenger RNA (mRNA) …
[HTML][HTML] Cervical cancer: Epidemiology, risk factors and screening
S Zhang, H Xu, L Zhang, Y Qiao - Chinese Journal of Cancer …, 2020 - ncbi.nlm.nih.gov
Cervical cancer is one of the leading causes of cancer death among females worldwide and
its behavior epidemiologically likes a venereal disease of low infectiousness. Early age at …
its behavior epidemiologically likes a venereal disease of low infectiousness. Early age at …
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression
Cervical squamous cell carcinoma (CESC) is a prototypical human cancer with well-
characterized pathological stages of initiation and progression. However, high-resolution …
characterized pathological stages of initiation and progression. However, high-resolution …
Cervical cancer immunotherapy: facts and hopes
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
[HTML][HTML] The role of m6A RNA methylation in cancer
T Sun, R Wu, L Ming - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Abstract N6-methyladenosine (m6A), the most abundant internal modification of RNA in
eukaryotic cells, has gained increasing attention in recent years. The m6A modification …
eukaryotic cells, has gained increasing attention in recent years. The m6A modification …
Anticancer properties of eugenol: A review
Conventional cancer treatments have shown several unfavourable adverse effects, as well
as an increase in anticancer drug resistance, which worsens the impending cancer therapy …
as an increase in anticancer drug resistance, which worsens the impending cancer therapy …
Cervical cancer worldwide
M Vu, J Yu, OA Awolude, L Chuang - Current problems in cancer, 2018 - Elsevier
Cervical cancer is the fourth most common cancer among women globally. The burden
faced by low-and middle-income countries is significantly greater than high-income …
faced by low-and middle-income countries is significantly greater than high-income …
Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years
S Lin, K Gao, S Gu, L You, S Qian, M Tang, J Wang… - Cancer, 2021 - Wiley Online Library
Background Cervical cancer is 1 of the most common cancers in females worldwide.
Understanding the most recent global patterns and temporal trends of cervical cancer …
Understanding the most recent global patterns and temporal trends of cervical cancer …
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic …
KS Tewari, MW Sill, RT Penson, H Huang… - The Lancet, 2017 - thelancet.com
Summary Background On Aug 14, 2014, the US Food and Drug Administration approved the
antiangiogenesis drug bevacizumab for women with advanced cervical cancer on the basis …
antiangiogenesis drug bevacizumab for women with advanced cervical cancer on the basis …